Literature DB >> 12505633

Tn7-mediated introduction of DNA sequences into bacmid-cloned cytomegalovirus genomes for rapid recombinant virus construction.

Gabriele Hahn1, Margit Jarosch, Jian Ben Wang, Carlos Berbes, Michael A McVoy.   

Abstract

Our basic understanding of how viruses infect, replicate, and cause disease has been largely derived from genetic approaches in which viral sequences have been mutated and the consequences of those mutations determined. In the herpesvirus field, deletions or insertions that preclude expression of specific viral proteins or remove critical cis elements have been invaluable in identifying their overall functions. We are now ready to move to a new level of detail-mapping functional domains within viral proteins or defining cis elements to the nucleotide level. This level of detail will require mutagenesis on a new scale, with recombinant viruses containing mutations within a given locus perhaps numbering in the hundreds. Mutagenesis on this scale would be greatly facilitated by more rapid methods of recombinant virus construction. In this report, we adapted a technology employing Tn7-mediated site-specific transposition [J. Virol. 67 (1993) 4566] as a rapid and highly reliable method to introduce novel sequences into bacmid-cloned herpesvirus genomes. We show that recombinant viruses can be rapidly created and that a deletion of the human cytomegalovirus (HCMV) essential gene ie2 can be complemented in cis by reintroduction, via transposition, of an ie2 cDNA; detailed mutagenesis of the complementing ie2 gene can now follow. Tn7-mediated transposition should accelerate greatly the pace at which recombinant herpesviruses can be constructed and, thus, facilitate the use of recombinant viruses for detailed mutagenic studies of both cis- and trans-acting genetic elements.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505633     DOI: 10.1016/s0166-0934(02)00232-x

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  12 in total

1.  Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells.

Authors:  Frances M Saccoccio; Anne L Sauer; Xiaohong Cui; Amy E Armstrong; El-Sayed E Habib; David C Johnson; Brent J Ryckman; Aloysius J Klingelhutz; Stuart P Adler; Michael A McVoy
Journal:  Vaccine       Date:  2011-02-22       Impact factor: 3.641

2.  A 128-base-pair sequence containing the pac1 and a presumed cryptic pac2 sequence includes cis elements sufficient to mediate efficient genome maturation of human cytomegalovirus.

Authors:  Jian Ben Wang; Michael A McVoy
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

3.  A human cytomegalovirus deleted of internal repeats replicates with near wild type efficiency but fails to undergo genome isomerization.

Authors:  Anne Sauer; Jian Ben Wang; Gabriele Hahn; Michael A McVoy
Journal:  Virology       Date:  2010-03-07       Impact factor: 3.616

4.  Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.

Authors:  Anokhi J Kapasi; Charles L Clark; Karen Tran; Deborah H Spector
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

5.  Cloning the complete guinea pig cytomegalovirus genome as an infectious bacterial artificial chromosome with excisable origin of replication.

Authors:  Xiaohong Cui; Alistair McGregor; Mark R Schleiss; Michael A McVoy
Journal:  J Virol Methods       Date:  2008-03-24       Impact factor: 2.014

6.  Definition of the minimal cis-acting sequences necessary for genome maturation of the herpesvirus murine cytomegalovirus.

Authors:  Jian Ben Wang; Daniel E Nixon; Michael A McVoy
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

7.  Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection.

Authors:  Anja Berndt; Heike Hofmann-Winkler; Nina Tavalai; Gabriele Hahn; Thomas Stamminger
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

8.  Mutagenesis of the murine cytomegalovirus M56 terminase gene.

Authors:  Jian Ben Wang; Michael A McVoy
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

9.  Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection.

Authors:  Xiaohong Cui; Benjamin P Meza; Stuart P Adler; Michael A McVoy
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

10.  Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.

Authors:  George Sourvinos; Nina Tavalai; Anja Berndt; Demetrios A Spandidos; Thomas Stamminger
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.